MICHAEL06 200 

Dr. Michael Nagel

Chief Executive Officer (CEO)

Prior to co-founding the company in 2014, Dr. Nagel initiated and led several research projects with a focus on Terahertz technology development. He received his PhD from the RWTH Aachen University in 2003. From 2004 on he worked in chief engineer position at the Institute of Semiconductor Electronics, RWTH Aachen. In 2011 he changed to AMO GmbH, where he initiated and led several Terahertz technology transfer projects. He has authored or co-authored over 160 publications and international conference presentations with more than 2700 citations and filed twelve patents.


SIMON05 200

Simon Sawallich

Chief Research Officer (CRO)

Mr. Sawallich studied physics at RWTH Aachen University, where he focused on experimental solid-state physics. During his studies, he gained further experience in the application of Terahertz technology at ENS Paris. After graduating in May 2012, he joined Protemics and is responsible for analytic services and research.


Advisory Board



Dr. Christopher Matheisen

Dr. Matheisen has extensive experience in the development and application of Terahertz technology. He studied physics at RWTH Aachen University and gained his PhD from the Institute of Semiconductor Electronics at RWTH Aachen University in 2013. Dr. Matheisen joined Protemics from 2012 - 2017 and is now an active member of the advisory board.


MARCEL07 200

Dr. Marcel Meuer

Dr. Meuer studied business administration at WHU – Otto Beisheim School of Management and the University of Michigan. He gained his PhD from the Innovation and Entrepreneurship group at RWTH Aachen in 2016. Dr. Meuer joined Protemics from 2012 – 2015 and is now an active member in the advisory board.

Fotos: © deFOTOGRAF viersen